Limited resection versus lobectomy for older patients with early-stage lung cancer: Impact of histology

Journal of Clinical Oncology

Volumn 33, Issue 30, 2015, Pages 3447-3453

  Veluswamy, Rajwanth R ^a   Ezer, Nicole ^a,c   Mhango, Grace ^a   Goodman, Emily ^a   Bonomi, Marcelo ^d   Neugut, Alfred I ^b   Swanson, Scott ^e   Powell, Charles A ^a   Beasley, Mary B ^a   Wisnivesky, Juan P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Columbia University ^*  (United States)

^c MCGILL UNIVERSITY   (Canada)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; COHORT ANALYSIS; DATA BASE; FEMALE; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; SQUAMOUS CELL LUNG CARCINOMA; SURVIVAL RATE; TUMOR VOLUME; WEDGE RESECTION; ADENOCARCINOMA; AGE; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; LUNG NEOPLASMS; PROCEDURES; UNITED STATES;

ADENOCARCINOMA; AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PNEUMONECTOMY; SEER PROGRAM; UNITED STATES;

EID: 84945237223     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.6624     Document Type: Article

References (49)

1. Spiro SG, Porter JC: Lung cancer: Where are we today? Current advances in staging and nonsurgical treatment. Am J Respir Crit Care Med 166: 1166-1196, 2002
2. Moyer VA, US Preventive Services Task Force: Screening for lung cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 160:330-338, 2014
3. Strand T-E, Rostad H, Møller B, et al: Survival after resection for primary lung cancer: A population based study of 3211 resected patients. Thorax 61: 710-715, 2006
4. National Comprehensive Cancer Network. Non-small-cell lung cancer (version 3.2014). http://www.nccn.org/professionals/physician-gls/pdf/nscl.pdf
5. Thomas P, Rubinstein L: Cancer recurrence after resection: T1 N0 non-small-cell lung cancer-Lung Cancer Study Group. Ann Thorac Surg 49:242-246, 1990; discussion 246-247
6. Koike T, Yamato Y, Yoshiya K, et al: Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 125:924-928, 2003
7. Okada M, Koike T, Higashiyama M, et al: Radical sublobar resection for small-sized non-small-cell lung cancer: A multicenter study. J Thorac Cardiovasc Surg 132:769-775, 2006
8. Wisnivesky JP, Henschke CI, Swanson S, et al: Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg 251:550-554, 2010
9. Keenan RJ, Landreneau RJ, Maley RH Jr, et al: Segmental resection spares pulmonary function in patients with stage I lung cancer. Ann Thorac Surg 78:228-233, 2004
10. Nakamura H, Kawasaki N, Taguchi M, et al: Survival following lobectomy versus limited resection for stage I lung cancer: A meta-analysis. Br J Cancer 92:1033-1037, 2005
11. Ost D, Goldberg J, Rolnitzky L, et al: Survival after surgery in stage IA and IB non-small-cell lung cancer. Am J Respir Crit Care Med 177:516-523, 2008
12. Travis WD, Brambilla E, Noguchi M, et al: International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6:244-285, 2011
13. Yoshizawa A, Sumiyoshi S, Sonobe M, et al: Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: Analysis of 440 Japanese patients. J Thorac Oncol 8:52-61, 2013
14. Russell PA, Wainer Z, Wright GM, et al: Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 6:1496-1504, 2011
15. Warren JL, Klabunde CN, Schrag D, et al: Overview of the SEER-Medicare data: Content, research applications, and generalizability to the United States elderly population. Med Care 40:3-18, 2002
16. Klabunde CN, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
17. Wisnivesky JP, Smith CB, Packer S, et al: Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: Observational cohort study. BMJ 343:d4013, 2011
18. Fritz A PC, Jack A: International Classification of Diseases for Oncology. Geneva, Switzerland, World Health Organization, 2000
19. National Cancer Institute: Surveillance, Epidemiology, and End Results. http://www.seer.cancer.gov.
20. Rezaei MK, Nolan NJ, Schwartz AM: Surgical pathology of lung cancer. Semin Respir Crit Care Med 34:770-786, 2013
21. Edge SB, Byrd DR, Compton CC, et al. (eds): AJCC Cancer Staging Manual (7th ed). New York, NY, Springer-Verlag, 2010
22. Warren JL, Harlan LC, Fahey A, et al: Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 40:IV-55-61, 2002 (suppl 8)
23. Rogers JL, Howard KI, Vessey JT: Using significance tests to evaluate equivalence between two experimental groups. Psychol Bull 113:553-565, 1993
24. Imai K, van Dyk DA: Causal inference with general treatment regimes: Generalizing the propensity score. J Am Stat Assoc 99:854-866, 2004
25. Walker E, Nowacki AS: Understanding equivalence and noninferiority testing. J Gen Intern Med 26:192-196, 2011
26. Rothmann M, Li N, Chen G, et al: Design and analysis of non-inferiority mortality trials in oncology. Stat Med 22:239-264, 2003
27. Patel AN, Santos RS, De Hoyos A, et al: Clinical trials of peripheral stage I (T1N0M0) non-small-cell lung cancer. Semin Thorac Cardiovasc Surg 15:421-430, 2003
28. Donington J, Ferguson M, Mazzone P, et al: American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small-cell lung cancer. Chest 142:1620-1635, 2012
29. Little AG, Rusch VW, Bonner JA, et al: Patterns of surgical care of lung cancer patients. Ann Thorac Surg 80:2051-2056, 2005; discussion 2056
30. Allen MS, Darling GE, Pechet TT, et al: Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 81:1013-1019, 2006; discussion 1019-1020
31. Sigel K, Bonomi M, Packer S, et al: Effect of age on survival of clinical stage I non-small-cell lung cancer. Ann Surg Oncol 16:1912-1917, 2009
32. Yoshizawa A, Motoi N, Riely GJ, et al: Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: Prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 24:653-664, 2011
33. Chansky K, Sculier JP, Crowley JJ, et al: The International Association for the Study of Lung Cancer staging project: Prognostic factors and pathologic TNM stage in surgically managed non-small-cell lung cancer. J Thorac Oncol 4:792-801, 2009
34. Kodama K, Higashiyama M, Yokouchi H, et al: Prognostic value of ground-glass opacity found in small lung adenocarcinoma on high-resolution CT scanning. Lung Cancer 33:17-25, 2001
35. Aoki T, Tomoda Y, Watanabe H, et al: Peripheral lung adenocarcinoma: Correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 220:803-809, 2001
36. Kondo T, Yamada K, Noda K, et al: Radiologic-prognostic correlation in patients with small pulmonary adenocarcinomas. Lung Cancer 36:49-57, 2002
37. Kuriyama K, Seto M, Kasugai T, et al: Ground-glass opacity on thin-section CT: Value in differentiating subtypes of adenocarcinoma of the lung. AJR Am J Roentgenol 173:465-469, 1999
38. Hashizume T, Yamada K, Okamoto N, et al: Prognostic significance of thin-section CT scan findings in small-sized lung adenocarcinoma. Chest 133: 441-447, 2008
39. Matsuguma H, Yokoi K, Anraku M, et al: Proportion of ground-glass opacity on highresolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung: A predictor of lymph node metastasis. J Thorac Cardiovasc Surg 124:278-284, 2002
40. Ohde Y, Nagai K, Yoshida J, et al: The proportion of consolidation to ground-glass opacity on high resolution CT is a good predictor for distinguishing the population of non-invasive peripheral adenocar-cinoma. Lung Cancer 42:303-310, 2003
41. Okada M, Nishio W, Sakamoto T, et al: Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J Thorac Cardiovasc Surg 127:857-861, 2004
42. Asamura H: Minimally invasive approach to early, peripheral adenocarcinoma with ground-glass opacity appearance. Ann Thorac Surg 85:S701-S704, 2008
43. Suzuki K, Koike T, Asakawa T, et al: A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 6:751-756, 2011
44. Suzuki K, Asamura H, Kusumoto M, et al. "Early" peripheral lung cancer: Prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 74: 1635-1639, 2002
45. Nana-Sinkam SP, Powell CA: Molecular biology of lung cancer: Diagnosis and management of ung cancer, 3rd ed-American College of Chest Physicians evidence-based clinical practice guideines. Chest 143:e30S-e39S, 2013 (suppl 5)
46. Heymann JJ, Bulman WA, Maxfield RA, et al. Molecular testing guidelines for lung adenocarcinoma: Utility of cell blocks and concordance between fine-needle aspiration cytology and histology samples. Cytojournal 11:12 2014
47. ClinicalTrials.gov: Comparison of different types of surgery in treating patients with stage IA non-small cell ung cancer. http://clinicaltrials.gov/ct2/show/NCT00499330?term=calgb+140503&rank=1
48. Rusch VW, Tsuchiya R, Tsuboi M, et al: Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: An evolving standard of care? J Thorac Oncol 1:S27-S31, 2006
49. Aberle DR, Adams AM, Berg CD, et al: Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 395-409, 2011